Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-26 @ 3:22 PM
Study NCT ID:
NCT01610492
Status:
COMPLETED
Last Update Posted:
2017-10-13
First Post:
2012-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-01
Start Date Type:
None
Primary Completion Date:
2014-09-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-31
First Submit QC Date:
None
Study First Post Date:
2012-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-11
Results First Submit QC Date:
None
Results First Post Date:
2015-06-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-12
Last Update Post Date:
2017-10-13
Last Update Post Date Type:
ACTUAL